Alle verbonden artikelen

Accuracy and other quality indicators of solid pancreatic mass endoscopic ultrasound-guided fine needle aspiration and biopsy in two academic endoscopy centers.

Auteurs : Figueiredo M, Arvanitakis M, Zaarour A, Toussaint E, Devière J, Van Laethem JL, Gomez-Galdon M, Verset L, Demetter P, Eisendrath P
Jaar : 2021
Journal : Acta Gastroenterol Belg
Volume : 84
Pagina's : 451-455

A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer.

Auteurs : Kotecki N, Vuagnat P, ONeil BH, Jalal S, Rottey S, Prenen H, Benhadji KA, Xia M, Szpurka AM, Saha A, Wallin J, Suriyapperuma S, Galvao VR, Geeganage S, Doman TN, Gandhi L, Xu X, Bendell J
Jaar : 2021
Journal : J Immunother
Volume : 44
Pagina's : 264-275

Complete response and renal cell carcinoma in the immunotherapy era: The paradox of good news.

Auteurs : Zambrana F, Carril-Ajuria L, Gómez de Liaño A, Martinez Chanza N, Manneh R, Castellano D, de Velasco G
Jaar : 2021
Journal : Cancer Treat Rev
Volume : 99
Pagina's : 102239

131I-metaiodobenzylguanidine and peptide receptor radionuclide therapy in pheochromocytoma and paraganglioma.

Auteurs : Jungels C, Karfis I
Jaar : 2021
Journal : Curr Opin Oncol
Volume : 33
Pagina's : 33-39

Identifying frailty in clinically fit patients diagnosed with hematological malignancies using a simple clinico-biological screening tool: The HEMA-4 study.

Auteurs : Thibaud V, Denève L, Dubruille S, Kenis C, Delforge M, Cattenoz C, Somme D, Wildiers H, Pepersack T, Lamy T, Bron D
Jaar : 2021
Journal : J Geriatr Oncol
Volume : 12
Pagina's : 902-908

Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial.

Auteurs : Martel S, Lambertini M, Agbor-Tarh D, Ponde NF, Gombos A, Paterson V, Hilbers F, Korde L, Manukyants A, Dueck A, Maurer C, Piccart-Gebhart M, Moreno-Aspitia A, Desmedt C, Di Cosimo S, de Azambuja E
Jaar : 2021
Journal : J Natl Compr Canc Netw
Volume : 19
Pagina's : 181-189

Nutrition education in medical schools (NEMS) project: Joining ESPEN and university point of view.

Auteurs : Cuerda C, Muscaritoli M, Krznaric Z, Pirlich M, Van Gossum A, Schneider S, Ellegard L, Fukushima R, Chourdakis M, Della Rocca C, Milovanovic D, Lember M, Arias-Diaz J, Stylianidis E, Anastasiadis K, Alunni V, Mars T, Hellerman MI, Irtun O, Abbasoglu O, Barazzoni R
Jaar : 2021
Journal : Clin Nutr
Volume : 40
Pagina's : 2754-2761

A Late Dermatologic Presentation of Bullous Pemphigoid Induced by Anti-PD-1 Therapy and Associated with Unexplained Neurological Disorder.

Auteurs : Wang X, Suppa M, Bruderer P, Sirtaine N, Aspeslagh S, Kerger J
Jaar : 2021
Journal : Case Rep Oncol
Volume : 14
Pagina's : 861-867

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).

Auteurs : Martinez Chanza N, Soukane L, Barthelemy P, Carnot A, Gil T, Casert V, Vanhaudenarde V, Sautois B, Staudacher L, Van Den Brande J, Culine S, Seront E, Gizzi M, Albisinni S, Tricard T, Fantoni JC, Paesmans M, Caparica R, Roumeguere T, Awada A
Jaar : 2021
Journal : BMC Cancer
Volume : 21
Pagina's : 1292

Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value.

Auteurs : Najem A, Wouters J, Krayem M, Rambow F, Sabbah M, Sales F, Awada A, Aerts S, Journe F, Marine JC, Ghanem GE
Jaar : 2021
Journal : Front Oncol
Volume : 11
Pagina's : 780654

Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial.

Auteurs : R Ferreira A, Ferreira S, Lambertini M, Maurer C, Martel S, Costa L, Ponde N, de Azambuja E
Jaar : 2021
Journal : Eur J Cancer
Volume : 144
Pagina's : 351-359

RTK Inhibitors in Melanoma: From Bench to Bedside.

Auteurs : Sabbah M, Najem A, Krayem M, Awada A, Journe F, Ghanem G
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer.

Auteurs : Partelli S, Sclafani F, Barbu ST, Beishon M, Bonomo P, Braz G, de Braud F, Brunner T, Cavestro GM, Crul M, Trill MD, Ferollà P, Herrmann K, Karamitopoulou E, Neuzillet C, Orsi F, Seppänen H, Torchio M, Valenti D, Zamboni G, Zins M, Costa A, Poortmans P
Jaar : 2021
Journal : Cancer Treat Rev
Pagina's : 102208

Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer.

Auteurs : Wrona E, Potemski P, Sclafani F, Borowiec M
Jaar : 2021
Journal : Arch Immunol Ther Exp (Warsz)
Volume : 69
Pagina's : 2

Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment.

Auteurs : Boisson A, Noël G, Saiselet M, Rodrigues-Vitória J, Thomas N, Fontsa ML, Sofronii D, Naveaux C, Duvillier H, Craciun L, Larsimont D, Awada A, Detours V, Willard-Gallo K, Garaud S
Jaar : 2021
Journal : Front Mol Biosci
Volume : 8
Pagina's : 673042

Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox.

Auteurs : Dubsky P, Pinker K, Cardoso F, Montagna G, Ritter M, Denkert C, Rubio IT, de Azambuja E, Curigliano G, Gentilini O, Gnant M, Günthert A, Hauser N, Heil J, Knauer M, Knotek-Roggenbauerc M, Knox S, Kovacs T, Kuerer HM, Loibl S, Mannhart M, Meattini I, Penault-Llorca F, Radosevic-Robin N, Sager P, Steyerova P, Tausch C, Peeters MTFDV, Weber WP, Cardoso MJ, Poortmans P
Jaar : 2021
Journal : Lancet Oncol
Volume : 22
Pagina's : e18-e28

Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis.

Auteurs : Dumont L, Salaroli A, Dal Lago L, Gil T, Pepersack T
Jaar : 2021
Journal : Eur J Case Rep Intern Med
Volume : 8
Pagina's : 002425

Response to letter entitled: Re: Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials.

Auteurs : Agostinetto E, Ceppi M, Bruzzone M, Lambertini M, de Azambuja E
Jaar : 2021
Journal : Eur J Cancer
Volume : 155
Pagina's : 303-306

Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.

Auteurs : Guerini-Rocco E, Gray KP, Fumagalli C, Reforgiato MR, Leone I, Rafaniello Raviele P, Munzone E, Kammler R, Neven P, Hitre E, Jerusalem G, Simoncini E, Gombos A, Deleu I, Karlsson P, Aebi S, Chirgwin J, Di Lauro V, Thompson A, Graas MP, Barber M, Fontaine C, Loibl S, Gavilá J, Kuroi K, Müller B, OReilly S, Di Leo A, Goldhirsch A, Viale G, Barberis M, Regan MM, Colleoni M
Jaar : 2021
Journal : Clin Cancer Res
Volume : 27
Pagina's : 504-512

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring.

Auteurs : Gyawali B, de Vries EGE, Dafni U, Amaral T, Barriuso J, Bogaerts J, Calles A, Curigliano G, Gomez-Roca C, Kiesewetter B, Oosting S, Passaro A, Pentheroudakis G, Piccart-Gebhart M, Roitberg F, Tabernero J, Tarazona N, Trapani D, Wester R, Zarkavelis G, Zielinski C, Zygoura P, Cherny NI
Jaar : 2021
Journal : ESMO Open
Volume : 6
Pagina's : 100117